Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Creasyn Finechem (Tianjin) Co., Ltd., now operating as CreaSyn Biotech and a subsidiary of Asymchem Group, is a China-based company specializing in the R&D, manufacturing, and commercialization of fine chemicals, pharmaceutical intermediates, and green health-oriented ingredients. Founded in 2008, the company leverages a robust synthetic biology platform to design and produce bioactive ingredients for the pharmaceutical, cosmetic, and food industries. Its expertise includes complex organic synthesis, such as free radical substitution and organometallic reactions, as well as the development of high-purity ingredients like pharmaceutical-grade creatine (CreaSyn™). As part of the Asymchem Group, it provides CDMO services and advances products from route design to pilot-scale manufacturing. The company is recognized for its ability to deliver high-quality, customizable ingredients with a focus on green chemistry and efficient production timelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creasyn Finechem.